Stockscreener 앱 받기
24.01
2.00%
-0.4933
전일 마감가:
$24.50
열려 있는:
$24.37
하루 거래량:
265.73K
Relative Volume:
0.05
시가총액:
$12.02B
수익:
$4.89B
순이익/손실:
$-242.00M
주가수익비율:
-49.09
EPS:
-0.489
순현금흐름:
$315.00M
1주 성능:
+0.42%
1개월 성능:
+8.54%
6개월 성능:
+2.78%
1년 성능:
+26.03%
1일 변동 폭
$23.96
$24.38
1주일 범위
$23.74
$25.07
52주 변동 폭
$18.22
$27.98
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
24.05 | 12.24B | 4.89B | -242.00M | 315.00M | -0.489 |
TAK
Takeda Pharmaceutical Co Adr
|
18.38 | 58.92B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.13 | 42.37B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.305 | 42.22B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
74.73 | 31.33B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
495.15 | 20.91B | 3.17B | 1.29B | 1.01B | 27.09 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | 업그레이드 | Argus | Hold → Buy |
| 2025-10-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Elanco Animal Health Stock Price Forecast. Should You Buy ELAN? - StockInvest.us
Elanco Director Purchases 40,000 Shares for $936,000 - Yahoo Finance
Elanco Director Purchases 40,000 Shares for $936,000 - The Motley Fool
Is Elanco Animal Health Inc (ELAN) Overvalued After 3.2% Rally? - GuruFocus
Pharma clinical research firm eyes former Elanco building in Greenfield - Indianapolis Business Journal
Elanco Animal Health (ELAN) Institutional Ownership 2026 $ELAN - MarketBeat
Elanco Scales Biologics Capabilities With Expansion of Kansas Manufacturing Facility - marketscreener.com
Elanco Says Demand for Its New Dog Treatment Is Twice What Was Expected - Stock Titan
Elanco (NYSE: ELAN) EVP now holds 9,770 deferred units - Stock Titan
Elanco (NYSE: ELAN) CFO holds 141.8242 deferred stock units - Stock Titan
Elanco Animal Health (ELAN) Stock Analysis: Unlocking a 30% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews
Elanco Animal Health (NYSE:ELAN) Director Lawrence Erik Kurzius Purchases 40,000 Shares - MarketBeat
Elanco director Kurzius buys $935,920 in company stock - Investing.com
Elanco Animal Health Director Purchased Shares Worth Over $935K - TradingView
Elanco (NYSE: ELAN) director buys 40K shares, stake now 188,647 - Stock Titan
Danske Bank A S Makes New $14.35 Million Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc (ELAN) Shares Fall 3.8% -- What GF Scor - GuruFocus
Stifel reiterates Buy rating on Elanco stock, $33 target By Investing.com - Investing.com Canada
245,707 Shares in Elanco Animal Health Incorporated $ELAN Purchased by Great Lakes Advisors LLC - MarketBeat
Elanco Animal Health: New Products To Support Growth (NYSE:ELAN) - Seeking Alpha
Attention investors: You may be eligible for a $15 million Elanco Animal Health SEC fair fund payment - Claim Depot
Elanco Animal Health (NYSE:ELAN): Is More Momentum Ahead? - Kalkine Media
CNBC Final Trades: Netflix, Eli Lilly, Elanco Animal Health & MoreNetflix (NASDAQ:NFLX), Eli Lilly (NY - Benzinga
160,631 Shares in Elanco Animal Health Incorporated $ELAN Purchased by First National Bank of Omaha - MarketBeat
Shiv O'neill Purchases 3,998 Shares of Elanco Animal Health (NYSE:ELAN) Stock - MarketBeat
Elanco (NYSE: ELAN) legal chief buys 3,998 company shares - Stock Titan
FRAUD AND MANIPULATION—7th Cir.: Panel affirms dismissal of channel-stuffing allegations - VitalLaw.com
S&CO Inc. Buys Shares of 111,284 Elanco Animal Health Incorporated $ELAN - MarketBeat
7th Circ. Won't Revive Elanco Investors' Securities Fraud Suit - Law360
Is Elanco Animal Health Inc (ELAN) Overvalued After 5.2% Rally? - GuruFocus
Elanco Investors Fail to Revive Sales Misrepresentation Suit (2) - Bloomberg Law News
Elanco's CLiK Extra Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species - FinanzNachrichten.de
5 Must-Read Analyst Questions From Elanco’s Q2 Earnings Call - Yahoo Finance
Elanco Animal Health (NYSE:ELAN) Director Buys 5,000 Shares - MarketBeat
Elanco Animal Health (ELAN) director purchases 5,000 shares of stock - Stock Titan
Elanco rating upgraded by Fitch on deleveraging progress - Investing.com Canada
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and ACADIA Pharmaceuticals (ACAD) - The Globe and Mail
Elanco Animal Health expands US screwworm response - foxbusiness.com
Elanco (ELAN): Innovation Is Turning A Leveraged Portfolio Into A Share-Taking Platform - Seeking Alpha
J.P. Morgan Maintains Elanco Animal Health(ELAN.US) With Buy Rating - Moomoo
Elanco Animal Health Incorporated (ELAN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Elanco Animal Health (ELAN) Insider Buying: EVP and CFO Robert V - GuruFocus
Elanco receives FDA emergency authorization for screwworm spray - Investing.com
Elanco's CLiK(TM) Extra (Dicyclanil Topical Suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Speci - ACCESS Newswire
Insider Buying: Elanco Animal Health (NYSE:ELAN) CFO Buys $96,936.00 in Stock - marketbeat.com
Insider Buying: Elanco Animal Health (NYSE:ELAN) Director Buys 10,000 Shares of Stock - MarketBeat
ELAN Stock Jumps As Earnings Beat Fuels Bullish Guidance - StocksToTrade
Elanco Animal Health (NYSE: ELAN) EVP granted new deferred stock units - Stock Titan
Elanco (ELAN) CFO boosts stake with 4,200-share buy and new Deferred Stock Units - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons receives new deferred stock unit grant - Stock Titan
Elanco Animal Health (NYSE: ELAN) director buys 10,000 shares at $23.69 - Stock Titan
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.42%
1.62%
자본화:
|
볼륨(24시간):